Distribution of delirium motor subtypes in the intensive care unit: a systematic scoping review

Table 2 Characteristics of patients with delirium

Characteristics of patients with delirium (n = 13,902)	Studies reporting on outcome (n)	Delirious patients in studies reporting on outcome (n)	Pooled mean or pooled proportion	95% CI
Age	96	12,112	66.9 years	65.4–68.5
Sex (male)	91	11,637	62.1%	60.2–64.0
Severity of disease
APACHEII	48	5897	18.9	17.5–20.3
SAPSII	10	1206	42.7	37.0–48.4
SAPSIII	2	285	52.2	33.2–71.2
SOFA	16	2046	7.8	6.3–9.3
Delirium-targeted pharmacological strategy*	21	3979	66.1%	55.4–76.8
Administration of specific agents**
Antipsychotics	33	5233	49.6%	39.2–60.0
α2-agonists	24	2474	26.3%	17.4–35.1
Benzodiazepines	38	3843	39.8%	31.2–48.5
Propofol	18	2057	42.4%	28.7–56.2
Length of stay
ICU	67	9813	9.2 days	8.0–10.4
Hospital	42	7889	19.8 days	17.6–22.1
Mortality
ICU	29	4519	17.0%	12.6–21.4
Hospital	18	1909	21.3%	14.0–28.6

APACHE Acute Physiology and Chronic Health Evaluation, SAPS Simplified Acute Physiology Score, SOFA Sequential Organ Failure Assessment
^*Patients intervened with a delirium-targeted pharmacological treatment strategy during ICU stay
^**Patients receiving administration of specific agents (as listed) while in the ICU with no limits to indication

ISSN: 1364-8535